1.6318
전일 마감가:
$1.86
열려 있는:
$1.77
하루 거래량:
1.77M
Relative Volume:
0.68
시가총액:
$9.33M
수익:
-
순이익/손실:
$-11.66M
주가수익비율:
-0.2001
EPS:
-8.156
순현금흐름:
$-11.09M
1주 성능:
-24.31%
1개월 성능:
-31.59%
6개월 성능:
-16.58%
1년 성능:
-49.07%
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
명칭
Phio Pharmaceuticals Corp
전화
(508) 767-3861
주소
411 SWEDELAND ROAD, KING OF PRUSSIA, MA
PHIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PHIO
Phio Pharmaceuticals Corp
|
1.63 | 10.65M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.27 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.19 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
841.40 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.54 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-05 | 재개 | H.C. Wainwright | Buy |
| 2020-08-05 | 개시 | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스
3 Penny Stocks to Watch Now, 11/4/25 - TipRanks
Is Phio Pharmaceuticals Corp. stock in correction or buying zoneJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com
How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policiesBull Run & Low Drawdown Investment Ideas - newser.com
Best data tools to analyze Phio Pharmaceuticals Corp. stock2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Will Phio Pharmaceuticals Corp. stock outperform tech sector in 2025July 2025 Momentum & Weekly Market Pulse Alerts - newser.com
Can Phio Pharmaceuticals Corp. rally from current levelsMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Phio Pharmaceuticals raises $13.4 million through warrant exercise By Investing.com - Investing.com Nigeria
Can PHIO Bounce Back? - timothysykes.com
Phio Pharmaceuticals Stock Falls 5% Amid Financing And Clinical Updates - Nasdaq
Phio Pharmaceuticals raises $13.4 million through warrant exercise - Investing.com
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds - Newsfile
Why Is Phio Pharmaceuticals Stock Soaring Today? - Benzinga
Why Is Phio Pharmaceuticals Stock Up 75% Today? - TipRanks
Phio Pharmaceuticals Reports Positive Phase 1b Trial Results - TipRanks
How Phio Pharmaceuticals Corp. stock benefits from tech adoptionChart Signals & AI Optimized Trading Strategy Guides - newser.com
Phio Pharmaceuticals Corp Announces Positive Results in Skin Cancer Trial - TradingView
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial - Newsfile
Is Phio Pharmaceuticals Corp. stock attractive for retirement portfolios2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com
Phio Pharmaceuticals Corp. stock retracement – recovery analysisMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
How Phio Pharmaceuticals Corp. (44R1) stock reacts to new regulations2025 Price Momentum & Risk Managed Trade Strategies - newser.com
How currency fluctuations impact Phio Pharmaceuticals Corp. stockTrade Exit Report & Comprehensive Market Scan Insights - newser.com
Can Phio Pharmaceuticals Corp. hit a new high this month2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Developing predictive dashboards with Phio Pharmaceuticals Corp. dataWeekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
What to do if you’re stuck in Phio Pharmaceuticals Corp.Quarterly Profit Report & Real-Time Buy Signal Notifications - newser.com
Top chart patterns to watch in Phio Pharmaceuticals Corp.Rate Cut & Technical Pattern Recognition Alerts - newser.com
Phio Pharmaceuticals appoints David Deming as lead independent director By Investing.com - Investing.com Australia
What drives Phio Pharmaceuticals Corp 44R1 stock priceAnalyst Downgrades & Access Insider-Level Stock Analysis - earlytimes.in
Phio Pharmaceuticals Corp. (PHIO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Phio Pharmaceuticals Appoints New Lead Independent Director - TipRanks
Phio Pharmaceuticals Corp. Announces Appointment of David H. Deming as Lead Independent Director - MarketScreener
[8-K] Phio Pharmaceuticals Corp. Reports Material Event | PHIO SEC FilingForm 8-K - Stock Titan
Phio Pharmaceuticals appoints David Deming as lead independent director - Investing.com
Phio Pharmaceuticals Announces Board Resignation - TradingView
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director - Newsfile
Phio (NASDAQ: PHIO) names David H. Deming lead independent director, with over 30 years - Stock Titan
Is Phio Pharmaceuticals Corp. stock supported by strong fundamentalsPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Using economic indicators to assess Phio Pharmaceuticals Corp. potential2025 Top Decliners & Fast Gain Swing Trade Alerts - newser.com
Will Phio Pharmaceuticals Corp. stock rally after Fed decisionsShort Setup & Low Drawdown Momentum Ideas - newser.com
Is Phio Pharmaceuticals Corp. (44R1) stock included in top ETFsWeekly Loss Report & Weekly Watchlist of Top Performers - newser.com
Phio Pharmaceuticals Corp (PHIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):